QT Holdings Corp.
BEVERLY, MA · Founded 2012 · CIK 0001605603 · Biotech · Acquired
Affinity chromatographic cell sorting system using dissolvable hydrogel microbeads for magnetic-particle-free cell purification
- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $3.8M
- 2 Form D · Sep 2015
- 133 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 3 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2013201420152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $475,000 | |
| Private capital raised | Form D · SEC | $3,285,938 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2169 | VISIONARY PHARMACEUTICALS, INC. | — | — |
| 2170 | Excision BioTherapeutics Inc. | — | $71M |
| 2171 | Context Therapeutics | — | $100M |
| 2172 | QT Holdings Corp. | — | $3.8M |
| 2173 | LOKI THERAPEUTICS, INC | — | — |
| 2174 | Aruvant Sciences | — | — |
| 2175 | Arena Therapeutics OpCo, Inc. | — | $600K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Sean KevlahanExecutive Officer
- Sean Kevlahan, Ph.D.Director · Executive Officer
- William MckenzieDirector
- Rebecca MenapaceDirector
- Shashi MurthyDirector
Patents
- Compositions, Devices, And Methods For Cell Separationgranted
- Shaped Articles Including Hydrogels And Methods Of Manufacture And Use Thereofgranted
- Methods And Compositions For Modulation Of Immune Cellsapplication
- Methods And Compositions For Activation Or Expansion Of T Lymphocytesgranted
- Shaped Articles Including Hydrogels And Methods Of Manufacture And Use Thereofapplication
- Methods And Compositions For Modulation Of Immune Cellsapplication
- Compositions, Devices, And Methods For Cell Separationapplication
- Methods And Compositions For Expansion Of T Lymphocytesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.